Clinical Utility of Transcatheter PFO Exploration in Cryptogenic Stroke Patients With Negative TEE but High Suspicion of PFO‐Related Etiology
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.70149 ↗At a glance
Journal article in Catheterization and Cardiovascular Interventions, 2025. Written by Luxi Guan and 5 co-authors. Institution: Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Major MEDLINE topics: Foramen Ovale, Patent, Echocardiography, Transesophageal, Cardiac Catheterization, Ischemic Stroke. Cited 3 times so far (Crossref); 25 references. Funded by: This work was supported by the Basic Research Expenses of the Central Public Welfare Research Institutes of the Chinese Academy of Medical Sciences (2022-RW320….
Topics: Schlaganfall
Abstract (original language)
Background
Patent foramen ovale (PFO) has been identified as a potential risk factor for cryptogenic stroke (CS). Although transesophageal echocardiography (TEE) is considered the gold standard for PFO detection, false‐negative results remain a clinical concern, particularly in CS patients with high suspicion of PFO‐related etiology.
Aims
To evaluate the clinical utility of transcatheter PFO exploration (TPFOE) in CS patients with negative TEE findings but high suspicion of PFO‐related etiology.
Methods
Between January 2019 and May 2022, 30 CS patients with high suspicion of PFO‐related etiology were enrolled. All showed grade III/IV RLS on contrast transthoracic echocardiography (cTTE) despite negative TEE. Each patient underwent TPFOE. Patients with confirmed PFO proceeded directly to immediate PFO closure, whereas negative cases received antiplatelet therapy alone. Follow‑up with transthoracic echocardiography (TTE), chest X‑ray, and electrocardiography (ECG) was performed at 12 h and at 1, 3, 6, and 12 months after the procedure.
Results
The study cohort comprised 14 males and 16 females, with a median age of 41.5 years (interquartile range: 34–48 years). TPFOE successfully identified PFO in 28 patients (93.3%), all of whom subsequently underwent successful interventional closure. Follow‐up TTE confirmed ideal device position and morphology without residual shunting. The remaining two patients (6.7%) had negative exploration results, and they received antiplatelet therapy alone. No recurrent cerebrovascular events were reported in any patient during the follow‐up period.
Conclusion
TEE, though the gold standard for PFO diagnosis, carries a non‑negligible false‑negative rate. In CS patients with negative TEE but high suspicion of PFO‐related etiology, TPFOE demonstrated potential as an adjunctive technique to increase PFO detection. Further studies are warranted to better define its diagnostic value for PFO in this patient population.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
ORCID profiles: Xiangbin Pan, Haibo Hu
Funding
- This work was supported by the Basic Research Expenses of the Central Public Welfare Research Institutes of the Chinese Academy of Medical Sciences (2022-RW320…
Cite
APA
Guan, L., Luo, D., Liu, M., Li, Z., Pan, X., & Hu, H. (2025). Clinical Utility of Transcatheter PFO Exploration in Cryptogenic Stroke Patients With Negative TEE but High Suspicion of PFO‐Related Etiology. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70149
Vancouver
Guan L, Luo D, Liu M, Li Z, Pan X, Hu H. Clinical Utility of Transcatheter PFO Exploration in Cryptogenic Stroke Patients With Negative TEE but High Suspicion of PFO‐Related Etiology. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70149
BibTeX
@article{Guan2025,
author = {Guan, Luxi and Luo, Dong and Liu, Meijun and Li, Zhengwei and Pan, Xiangbin and Hu, Haibo},
title = {Clinical Utility of Transcatheter PFO Exploration in Cryptogenic Stroke Patients With Negative TEE but High Suspicion of PFO‐Related Etiology},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.70149}
}
EUVIMED